Impact Analysis of Covid-19 On Global Computational Biology Market Continues to Expand to Support Development and Top Players: Accelrys, Certara, L.P., Chemical Computing Group, Compugen, Ltd

Developing computer networks for surveillance of disease and mapping the pathways and biological networks associated with the initiation is expected to offer lucrative growth opportunities for players in the global computational biology market. Moreover, increasing prevalence of chronic disorders is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Increasing focus on reducing cost of drug development has led to manufacturers to adopt 3D modeling systems to analyze samples. Use of 3D modeling systems aids in recording rare cell events, accurate cell counts, improved sensitivity of detection, thereby accelerating the drug discovery process.

Get a sample copy @: https://www.coherentmarketinsights.com/insight/request-sample/3915

Major players in the market are focused on launching products and services that aid in treatment and management of Covid-19. For instance, in April 2020, Certara L.P. launched the COVID-19 Pharmacology Resource Center to help advance therapeutics for COVID-19.

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in May 2020, Genedata, AG launched Genedata Imagence 2.0, the latest version of its enterprise software for high-content screening (HCS) image analysis.

Major players in the market are also focused on adopting collaboration strategies to enhance their market share. For instance, in March 2019, Rosa & Co. LLC collaborated with Chugai Pharmaceutical Co., Ltd. Under the collaboration Rosa & Co. LLC will provide its PhysioPD research services for R&D in multiple therapeutic areas.

High cost of drug development is expected to propel growth of the global computational biology market over the forecast period. For instance, according to an analysis published in JAMA in March 2020, U.S. biopharmaceutical companies spent around US$ 1 billion to bring each of their new drugs to market between 2009 and 2018.

Moreover, several benefits of computational biology are also expected to aid in growth of the market. Predictive modeling tools in computational biology can provide invaluable information to better streamline drug development process. Predictive modelling helps to reduce the total number of recruited patients and to shorten the duration of clinical trials.

Major players operating in the global computational biology market include, Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.

Get Your Copy at a Discount@ https://www.coherentmarketinsights.com/insight/request-discount/3915

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.